Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Max A. Little
Based on 13 articles published since 2008
||||
Expertise Level
The expertise of Max A. Little ranks in the
  • Top 2%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 13 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Little, Max   ·   Little, M   ·   Little, Max A   ·   Little, M A
Work Locations
Details
Most likely:    Massachusetts Institute of Technology      
2018
  • Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; CAPES Foundation, Ministry of Education of Brazil, Brasília/DF, Brazil. Electronic address: · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; Institute for Computing and Information Sciences, Nijmegen, The Netherlands. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands. · The Michael J Fox Foundation for Parkinson's Research, New York, USA. · UCB Biopharma, Monheim, Germany. · UCB Biopharma Slough, United Kingdom. · Aston University, Birmingham, UK; Media Lab, Massachusetts Institute of Technology, Cambridge, USA. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, The Netherlands. · Pubmed 29627498
2017
  • Radboud university medical center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands. · CAPES Foundation, Ministry of Education of Brazil, Brasília, DF, Brazil. · Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands. · Michael J Fox Foundation for Parkinson's Research, New York, USA. · Aston University, Birmingham, UK. · Media Lab, Massachusetts Institute of Technology, Cambridge, USA. · Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan. · Radboud university medical center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Radboud university medical center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, The Netherlands. · Pubmed 28251357
  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. · CAPES Foundation, Ministry of Education of Brazil, Brasília/DF, Brazil. · Intel, Advanced Analytics, Tel Aviv, Israel. · The Michael J Fox Foundation for Parkinson's Research, New York, United States of America. · UCB Biopharma, Brussels, Belgium. · Aston University, Birmingham, United Kingdom. · Media Lab, Massachusetts Institute of Technology, Cambridge, United States of America. · Philips Research, Department Personal Health, Eindhoven, the Netherlands. · Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, the Netherlands. · Pubmed 29261709
2016
  • Department of Data Science, tranSMART Foundation, Wakefield, Massachusetts, USA. · Verge Genomics, San Francisco, California, USA. · Interdepartmental Program in Bioinformatics, University of California at Los Angeles, Los Angeles, California, USA. · Aston University, Aston Triangle, Birmingham, United Kingdom. · Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Pubmed 27501026
  • James J. and Joan A. Gardner Family Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, USA. · Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA. · Department of Neurosciences, University of California San Diego, La Jolla, CA, USA. · Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tübingen, Germany. · DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Davis Phinney Foundation for Parkinson's, Boulder, Colorado, USA. · Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. · Digital Sports Group, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. · Department of Neuroscience "Rita Levi Montalcini", Città della salute e della scienza di Torino, Torino, Italy. · Department of Neurology, Oregon Health & Science University, Portland VA Medical System, Portland, Oregon. · APDM, Inc., Portland, Oregon, USA. · Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · George-Huntington-Institute, Muenster, Germany. · Department of Radiology, University of Muenster, Muenster, Germany. · Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. · Great Lakes NeuroTechnologies, Cleveland, Ohio, USA. · Neuromotor Rehabilitation Research Group, Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium. · Global Kinetics Corporation & Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. · Department of Mathematics, Aston University, Birmingham, UK. · Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA. · Michael J Fox Foundation for Parkinson's Research, New York City, New York, USA. · Department of Neurology, National Institute of Clinical Neurosciences, Budapest, Hungary. · Center of Interdisciplinary Research Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz, Monte de Caparica, Portugal. · Apptomics LLC, Wellesley, Massachusetts, USA. · Medtronic Neuromodulation, Minneapolis, Minnesota, USA. · Sackler School of Medicine, Tel Aviv University and Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, the Netherlands. · Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 27125836
2015
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • Nonlinearity and Complexity Research Group, Aston University, Birmingham, United Kingdom; Somerville College, University of Oxford, Oxford, United Kingdom. · Duke University School of Medicine, Durham, NC, United States. · Johns Hopkins University, Baltimore, MD, United States. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States; CHET, University of Rochester Medical Center, Rochester, NY, United States. Electronic address: · Nonlinearity and Complexity Research Group, Aston University, Birmingham, United Kingdom; Media Lab, Massachusetts Institute of Technology, Boston, MA, United States. · Pubmed 25819808
2013
  • Human Dynamics Group, Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, United States. · Pubmed 23343503
Probable:    Aston University      
2018
  • Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; CAPES Foundation, Ministry of Education of Brazil, Brasília/DF, Brazil. Electronic address: · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; Institute for Computing and Information Sciences, Nijmegen, The Netherlands. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands. · The Michael J Fox Foundation for Parkinson's Research, New York, USA. · UCB Biopharma, Monheim, Germany. · UCB Biopharma Slough, United Kingdom. · Aston University, Birmingham, UK; Media Lab, Massachusetts Institute of Technology, Cambridge, USA. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, The Netherlands. · Pubmed 29627498
2017
  • Radboud university medical center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands. · CAPES Foundation, Ministry of Education of Brazil, Brasília, DF, Brazil. · Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands. · Michael J Fox Foundation for Parkinson's Research, New York, USA. · Aston University, Birmingham, UK. · Media Lab, Massachusetts Institute of Technology, Cambridge, USA. · Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan. · Radboud university medical center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Radboud university medical center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, The Netherlands. · Pubmed 28251357
  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. · CAPES Foundation, Ministry of Education of Brazil, Brasília/DF, Brazil. · Intel, Advanced Analytics, Tel Aviv, Israel. · The Michael J Fox Foundation for Parkinson's Research, New York, United States of America. · UCB Biopharma, Brussels, Belgium. · Aston University, Birmingham, United Kingdom. · Media Lab, Massachusetts Institute of Technology, Cambridge, United States of America. · Philips Research, Department Personal Health, Eindhoven, the Netherlands. · Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, the Netherlands. · Pubmed 29261709
2016
  • Department of Data Science, tranSMART Foundation, Wakefield, Massachusetts, USA. · Verge Genomics, San Francisco, California, USA. · Interdepartmental Program in Bioinformatics, University of California at Los Angeles, Los Angeles, California, USA. · Aston University, Aston Triangle, Birmingham, United Kingdom. · Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Pubmed 27501026
  • James J. and Joan A. Gardner Family Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, USA. · Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA. · Department of Neurosciences, University of California San Diego, La Jolla, CA, USA. · Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tübingen, Germany. · DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Davis Phinney Foundation for Parkinson's, Boulder, Colorado, USA. · Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. · Digital Sports Group, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. · Department of Neuroscience "Rita Levi Montalcini", Città della salute e della scienza di Torino, Torino, Italy. · Department of Neurology, Oregon Health & Science University, Portland VA Medical System, Portland, Oregon. · APDM, Inc., Portland, Oregon, USA. · Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · George-Huntington-Institute, Muenster, Germany. · Department of Radiology, University of Muenster, Muenster, Germany. · Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. · Great Lakes NeuroTechnologies, Cleveland, Ohio, USA. · Neuromotor Rehabilitation Research Group, Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium. · Global Kinetics Corporation & Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. · Department of Mathematics, Aston University, Birmingham, UK. · Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA. · Michael J Fox Foundation for Parkinson's Research, New York City, New York, USA. · Department of Neurology, National Institute of Clinical Neurosciences, Budapest, Hungary. · Center of Interdisciplinary Research Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz, Monte de Caparica, Portugal. · Apptomics LLC, Wellesley, Massachusetts, USA. · Medtronic Neuromodulation, Minneapolis, Minnesota, USA. · Sackler School of Medicine, Tel Aviv University and Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, the Netherlands. · Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 27125836
2015
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • Nonlinearity and Complexity Research Group, Aston University, Birmingham, United Kingdom; Somerville College, University of Oxford, Oxford, United Kingdom. · Duke University School of Medicine, Durham, NC, United States. · Johns Hopkins University, Baltimore, MD, United States. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States; CHET, University of Rochester Medical Center, Rochester, NY, United States. Electronic address: · Nonlinearity and Complexity Research Group, Aston University, Birmingham, United Kingdom; Media Lab, Massachusetts Institute of Technology, Boston, MA, United States. · Pubmed 25819808
Possible:    Oxford University      
2012
  • Oxford Centre for Industrial and Applied Mathematics (OCIAM), Mathematical Institute, University of Oxford, Oxford, UK. · Pubmed 22249592
2011
  • Systems Analysis, Modelling and Prediction (SAMP) group, Mathematical Institute and Department of Engineering Science, University of Oxford, Oxford, UK. · Pubmed 21084338
2010
  • Systems Analysis Modelling and Prediction Group, University of Oxford, Oxford, OX1 3PJ, UK. · Pubmed 19932995
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by Max A. Little about Parkinson Disease:

  • Impact of motor fluctuations on real-life gait in Parkinson's patients. 2018
  • Freezing of gait and fall detection in Parkinson's disease using wearable sensors: a systematic review. 2017
  • Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease. 2017
  • Machine learning for large-scale wearable sensor data in Parkinson's disease: Concepts, promises, pitfalls, and futures. 2016
  • Technology in Parkinson's disease: Challenges and opportunities. 2016
  • Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's Disease. 2015
  • Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study. 2015
  • Objective Automatic Assessment of Rehabilitative Speech Treatment in Parkinson's Disease. 2014
  • Quantifying short-term dynamics of Parkinson's disease using self-reported symptom data from an Internet social network. 2013
  • Novel speech signal processing algorithms for high-accuracy classification of Parkinson's disease. 2012
Show List of Full Article Records
Google Searches

Learn more about Max A. Little using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Massachusetts Institute of Technology
Aston University
Oxford University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Massachusetts Institute of Technology
2018
  • Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; CAPES Foundation, Ministry of Education of Brazil, Brasília/DF, Brazil. Electronic address: · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; Institute for Computing and Information Sciences, Nijmegen, The Netherlands. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands. · The Michael J Fox Foundation for Parkinson's Research, New York, USA. · UCB Biopharma, Monheim, Germany. · UCB Biopharma Slough, United Kingdom. · Aston University, Birmingham, UK; Media Lab, Massachusetts Institute of Technology, Cambridge, USA. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, The Netherlands. · Pubmed 29627498
2017
  • Radboud university medical center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands. · CAPES Foundation, Ministry of Education of Brazil, Brasília, DF, Brazil. · Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands. · Michael J Fox Foundation for Parkinson's Research, New York, USA. · Aston University, Birmingham, UK. · Media Lab, Massachusetts Institute of Technology, Cambridge, USA. · Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan. · Radboud university medical center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Radboud university medical center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, The Netherlands. · Pubmed 28251357
  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. · CAPES Foundation, Ministry of Education of Brazil, Brasília/DF, Brazil. · Intel, Advanced Analytics, Tel Aviv, Israel. · The Michael J Fox Foundation for Parkinson's Research, New York, United States of America. · UCB Biopharma, Brussels, Belgium. · Aston University, Birmingham, United Kingdom. · Media Lab, Massachusetts Institute of Technology, Cambridge, United States of America. · Philips Research, Department Personal Health, Eindhoven, the Netherlands. · Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, the Netherlands. · Pubmed 29261709
2016
  • Department of Data Science, tranSMART Foundation, Wakefield, Massachusetts, USA. · Verge Genomics, San Francisco, California, USA. · Interdepartmental Program in Bioinformatics, University of California at Los Angeles, Los Angeles, California, USA. · Aston University, Aston Triangle, Birmingham, United Kingdom. · Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Pubmed 27501026
  • James J. and Joan A. Gardner Family Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, USA. · Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA. · Department of Neurosciences, University of California San Diego, La Jolla, CA, USA. · Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tübingen, Germany. · DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Davis Phinney Foundation for Parkinson's, Boulder, Colorado, USA. · Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. · Digital Sports Group, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. · Department of Neuroscience "Rita Levi Montalcini", Città della salute e della scienza di Torino, Torino, Italy. · Department of Neurology, Oregon Health & Science University, Portland VA Medical System, Portland, Oregon. · APDM, Inc., Portland, Oregon, USA. · Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · George-Huntington-Institute, Muenster, Germany. · Department of Radiology, University of Muenster, Muenster, Germany. · Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. · Great Lakes NeuroTechnologies, Cleveland, Ohio, USA. · Neuromotor Rehabilitation Research Group, Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium. · Global Kinetics Corporation & Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. · Department of Mathematics, Aston University, Birmingham, UK. · Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA. · Michael J Fox Foundation for Parkinson's Research, New York City, New York, USA. · Department of Neurology, National Institute of Clinical Neurosciences, Budapest, Hungary. · Center of Interdisciplinary Research Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz, Monte de Caparica, Portugal. · Apptomics LLC, Wellesley, Massachusetts, USA. · Medtronic Neuromodulation, Minneapolis, Minnesota, USA. · Sackler School of Medicine, Tel Aviv University and Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, the Netherlands. · Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 27125836
2015
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • Nonlinearity and Complexity Research Group, Aston University, Birmingham, United Kingdom; Somerville College, University of Oxford, Oxford, United Kingdom. · Duke University School of Medicine, Durham, NC, United States. · Johns Hopkins University, Baltimore, MD, United States. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States; CHET, University of Rochester Medical Center, Rochester, NY, United States. Electronic address: · Nonlinearity and Complexity Research Group, Aston University, Birmingham, United Kingdom; Media Lab, Massachusetts Institute of Technology, Boston, MA, United States. · Pubmed 25819808
2013
  • Human Dynamics Group, Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, United States. · Pubmed 23343503
Aston University
2018
  • Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; CAPES Foundation, Ministry of Education of Brazil, Brasília/DF, Brazil. Electronic address: · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; Institute for Computing and Information Sciences, Nijmegen, The Netherlands. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands. · The Michael J Fox Foundation for Parkinson's Research, New York, USA. · UCB Biopharma, Monheim, Germany. · UCB Biopharma Slough, United Kingdom. · Aston University, Birmingham, UK; Media Lab, Massachusetts Institute of Technology, Cambridge, USA. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands; Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, The Netherlands. · Pubmed 29627498
2017
  • Radboud university medical center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands. · CAPES Foundation, Ministry of Education of Brazil, Brasília, DF, Brazil. · Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands. · Michael J Fox Foundation for Parkinson's Research, New York, USA. · Aston University, Birmingham, UK. · Media Lab, Massachusetts Institute of Technology, Cambridge, USA. · Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan. · Radboud university medical center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Radboud university medical center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, The Netherlands. · Pubmed 28251357
  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. · CAPES Foundation, Ministry of Education of Brazil, Brasília/DF, Brazil. · Intel, Advanced Analytics, Tel Aviv, Israel. · The Michael J Fox Foundation for Parkinson's Research, New York, United States of America. · UCB Biopharma, Brussels, Belgium. · Aston University, Birmingham, United Kingdom. · Media Lab, Massachusetts Institute of Technology, Cambridge, United States of America. · Philips Research, Department Personal Health, Eindhoven, the Netherlands. · Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Nijmegen, the Netherlands. · Pubmed 29261709
2016
  • Department of Data Science, tranSMART Foundation, Wakefield, Massachusetts, USA. · Verge Genomics, San Francisco, California, USA. · Interdepartmental Program in Bioinformatics, University of California at Los Angeles, Los Angeles, California, USA. · Aston University, Aston Triangle, Birmingham, United Kingdom. · Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Pubmed 27501026
  • James J. and Joan A. Gardner Family Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, USA. · Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA. · Department of Neurosciences, University of California San Diego, La Jolla, CA, USA. · Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tübingen, Germany. · DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Davis Phinney Foundation for Parkinson's, Boulder, Colorado, USA. · Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. · Digital Sports Group, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. · Department of Neuroscience "Rita Levi Montalcini", Città della salute e della scienza di Torino, Torino, Italy. · Department of Neurology, Oregon Health & Science University, Portland VA Medical System, Portland, Oregon. · APDM, Inc., Portland, Oregon, USA. · Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · George-Huntington-Institute, Muenster, Germany. · Department of Radiology, University of Muenster, Muenster, Germany. · Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. · Great Lakes NeuroTechnologies, Cleveland, Ohio, USA. · Neuromotor Rehabilitation Research Group, Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium. · Global Kinetics Corporation & Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. · Department of Mathematics, Aston University, Birmingham, UK. · Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA. · Michael J Fox Foundation for Parkinson's Research, New York City, New York, USA. · Department of Neurology, National Institute of Clinical Neurosciences, Budapest, Hungary. · Center of Interdisciplinary Research Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz, Monte de Caparica, Portugal. · Apptomics LLC, Wellesley, Massachusetts, USA. · Medtronic Neuromodulation, Minneapolis, Minnesota, USA. · Sackler School of Medicine, Tel Aviv University and Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, the Netherlands. · Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 27125836
2015
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • Nonlinearity and Complexity Research Group, Aston University, Birmingham, United Kingdom; Somerville College, University of Oxford, Oxford, United Kingdom. · Duke University School of Medicine, Durham, NC, United States. · Johns Hopkins University, Baltimore, MD, United States. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States; CHET, University of Rochester Medical Center, Rochester, NY, United States. Electronic address: · Nonlinearity and Complexity Research Group, Aston University, Birmingham, United Kingdom; Media Lab, Massachusetts Institute of Technology, Boston, MA, United States. · Pubmed 25819808
Oxford University
2012
  • Oxford Centre for Industrial and Applied Mathematics (OCIAM), Mathematical Institute, University of Oxford, Oxford, UK. · Pubmed 22249592
2011
  • Systems Analysis, Modelling and Prediction (SAMP) group, Mathematical Institute and Department of Engineering Science, University of Oxford, Oxford, UK. · Pubmed 21084338
2010
  • Systems Analysis Modelling and Prediction Group, University of Oxford, Oxford, OX1 3PJ, UK. · Pubmed 19932995
Yearly article counts 012221121100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.